Spectranetics (SPNC) Misses Q2 EPS by 27c, Beats on Revenues

Spectranetics (NASDAQ: SPNC) reported Q2 EPS of ($0.56), $0.27 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $74.7 million versus the consensus estimate of $73.82 million.

• Revenue of $74.7 million increased 10% (11% constant currency1)
• Vascular Intervention revenue of $51.0 million increased 10% (11% constant currency1)
• Lead Management revenue of $19.7 million increased 11% (12% constant currency1)

Net loss for the three months ended June 30, 2017 was $24.6 million, or $0.56 per share, compared with net loss of $14.9 million, or $0.35 per share, for the three months ended June 30, 2016.

For earnings history and earnings-related data on Spectranetics (SPNC) click here.

You May Also Be Interested In

• SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
• Ford Motor Q3 vehicle sales fall 6.6%, F-Series leads gains
• Alethia Capital Starts TTM Technologies (TTMI) at Overweight, 'A Unique Proxy Standing for USA PCB'